These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Blood glucose lowering property of water in oral insulin-fed diabetic rats. Wong TW; Sumiran N; Mokhtar MT; Kadir A Pharm Biol; 2012 Nov; 50(11):1463-6. PubMed ID: 22889006 [TBL] [Abstract][Full Text] [Related]
23. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation. Akram M; Naqvi SB; Khan A Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203 [TBL] [Abstract][Full Text] [Related]
24. Deposition of insulin powders for inhalation in vitro and pharmacodynamic evaluation of absorption promoters in rats. Yang DB; Zhu JB; Zhu H; Zhang XS Yao Xue Xue Bao; 2005 Dec; 40(12):1069-74. PubMed ID: 16496667 [TBL] [Abstract][Full Text] [Related]
25. Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin. Peng Q; Sun X; Gong T; Wu CY; Zhang T; Tan J; Zhang ZR Acta Biomater; 2013 Feb; 9(2):5063-9. PubMed ID: 23036950 [TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of monomethoxypoly(ethylene glycol)-insulin conjugates. Zhang M; Dou H; Yin L; Zhang Y; Zhu S; Yin C Pharmazie; 2009 Mar; 64(3):190-6. PubMed ID: 19348342 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs. Plum A; Agerso H; Andersen L Drug Metab Dispos; 2000 Feb; 28(2):155-60. PubMed ID: 10640512 [TBL] [Abstract][Full Text] [Related]
28. [Effect of a new hypoglycemic drug on the blood sugar in rats]. Perán S; De Diego AM; Arcas F; Maté A; Morell M Rev Iber Endocrinol; 1976; 23(134):171-8. PubMed ID: 935732 [TBL] [Abstract][Full Text] [Related]
29. Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components. Beppu H; Shimpo K; Chihara T; Kaneko T; Tamai I; Yamaji S; Ozaki S; Kuzuya H; Sonoda S J Ethnopharmacol; 2006 Feb; 103(3):468-77. PubMed ID: 16406411 [TBL] [Abstract][Full Text] [Related]
30. Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system. Kim BY; Jeong JH; Park K; Kim JD J Control Release; 2005 Feb; 102(3):525-38. PubMed ID: 15681076 [TBL] [Abstract][Full Text] [Related]
31. Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations. Lee JJ; Yi HY; Yang JW; Shin JS; Kwon JH; Kim CW Biosci Biotechnol Biochem; 2003 Nov; 67(11):2396-401. PubMed ID: 14646199 [TBL] [Abstract][Full Text] [Related]
32. [Protective effects of continue insulin infusion on liver mitochondrion in the early stage of septic rats]. Zeng QY; Zhang CM; Qian XH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jun; 25(6):525-8. PubMed ID: 19500508 [TBL] [Abstract][Full Text] [Related]
33. Insulin in w/o/w multiple emulsions: biological activity after oral administration in normal and diabetic rats. Cunha AS; Grossiord JL; Puisieux F; Seiller M J Microencapsul; 1997; 14(3):321-33. PubMed ID: 9147282 [TBL] [Abstract][Full Text] [Related]
34. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy. Zhao YZ; Li X; Lu CT; Xu YY; Lv HF; Dai DD; Zhang L; Sun CZ; Yang W; Li XK; Zhao YP; Fu HX; Cai L; Lin M; Chen LJ; Zhang M Acta Diabetol; 2012 Aug; 49(4):315-25. PubMed ID: 22124766 [TBL] [Abstract][Full Text] [Related]
35. Controlled release of insulin from self-assembling nanofiber hydrogel, PuraMatrix™: application for the subcutaneous injection in rats. Nishimura A; Hayakawa T; Yamamoto Y; Hamori M; Tabata K; Seto K; Shibata N Eur J Pharm Sci; 2012 Jan; 45(1-2):1-7. PubMed ID: 22064453 [TBL] [Abstract][Full Text] [Related]
36. Reversible pegylation of insulin facilitates its prolonged action in vivo. Shechter Y; Mironchik M; Rubinraut S; Tsubery H; Sasson K; Marcus Y; Fridkin M Eur J Pharm Biopharm; 2008 Sep; 70(1):19-28. PubMed ID: 18495444 [TBL] [Abstract][Full Text] [Related]
37. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin. Rastogi R; Anand S; Koul V Drug Dev Ind Pharm; 2010 Nov; 36(11):1303-11. PubMed ID: 20849347 [TBL] [Abstract][Full Text] [Related]
38. Comparing the enhancement efficiency between liposomes and microbubbles for insulin pulmonary absorption. Xu YY; Lu CT; Fu HX; Zhao YZ; Yang W; Li X; Zhang L; Li XK; Zhang M Diabetes Technol Ther; 2011 Jul; 13(7):759-65. PubMed ID: 21510752 [TBL] [Abstract][Full Text] [Related]
39. Nanosphere based oral insulin delivery. Carino GP; Jacob JS; Mathiowitz E J Control Release; 2000 Mar; 65(1-2):261-9. PubMed ID: 10699286 [TBL] [Abstract][Full Text] [Related]
40. Influence of glutathione on the bioactivity of subcutaneously or orally administered insulin to rats. Al-Kurdi ZI; Chowdhry BZ; Leharne SA; Qinna NA; Al-Omari MM; Badwan AA Protein Pept Lett; 2015; 22(6):489-96. PubMed ID: 25896162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]